Observational studyArthritis research & therapy2019

Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registry.

Denis Choquette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.